Fineline Cube

Follow:
14435 Articles
MSD China Reorganizes to Boost Mature Product Lines
Company

MSD China Reorganizes to Boost Mature Product Lines

Suzhou Abogen's RSV mRNA Vaccine IND Approved by China's CDE
CompanyDrug

Suzhou Abogen’s RSV mRNA Vaccine IND Approved by China’s CDE

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D
Policy / Regulatory

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D

BeiGene's Tevimbra Receives FDA Approval for ESCC Treatment
CompanyDrug

BeiGene’s Tevimbra Receives FDA Approval for ESCC Treatment

Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars
Company

Organon’s 2024 Financial Report Shows Steady Growth in Women’s Health and Biosimilars

AstraZeneca and Daiichi Sankyo's Enhertu Shows Positive Results in Phase III Study
CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Shows Positive Results in Phase III Study

Boehringer Ingelheim Appeals CNIPA's Invalidation of Jardiance Patents
Company

Boehringer Ingelheim Appeals CNIPA’s Invalidation of Jardiance Patents

Genentech's TNKase Approved by FDA for Acute Ischemic Stroke Treatment
CompanyDrug

Genentech’s TNKase Approved by FDA for Acute Ischemic Stroke Treatment

Eisai's Lecanemab Rejected by Australia's TGA for Early Alzheimer's Treatment
CompanyDrug

Eisai’s Lecanemab Rejected by Australia’s TGA for Early Alzheimer’s Treatment

Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio
CompanyDeals

Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio

Fapon Biopharma's FP008 Receives FDA Approval for Clinical Trials
CompanyDrug

Fapon Biopharma’s FP008 Receives FDA Approval for Clinical Trials

Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development
CompanyDeals

Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development